{
    "organizations": [],
    "uuid": "8ea4e583ee57cb19a63a0ed82b620afe172b53a9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-china-traditional-chinese-medicine/brief-china-traditional-chinese-medicine-announces-investments-in-jiangkang-pharmaceutical-and-shuanglanxing-idUSFWN1QO0N7",
    "ord_in_thread": 0,
    "title": "BRIEF-China Traditional Chinese Medicine Announces Investments In Jiangkang Pharmaceutical And Shuanglanxing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - China Traditional Chinese Medicine Holdings Co Ltd:\n* UNIT ‍TO INJECT CAPITAL OF RMB46.94 MILLION & RMB35.10 MILLION INTO JIANGKANG PHARMACEUTICAL & SHUANGLANXING RESPECTIVELY​\n* TIANJIANG PHARMACEUTICAL WILL HOLD 51% EQUITY INTEREST IN EACH OF JIANGKANG PHARMACEUTICAL AND SHUANGLANXING​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T23:08:00.000+02:00",
    "crawled": "2018-03-07T19:28:43.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "china",
        "traditional",
        "chinese",
        "medicine",
        "holding",
        "co",
        "ltd",
        "unit",
        "inject",
        "capital",
        "million",
        "million",
        "jiangkang",
        "pharmaceutical",
        "shuanglanxing",
        "tianjiang",
        "pharmaceutical",
        "hold",
        "equity",
        "interest",
        "jiangkang",
        "pharmaceutical",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}